Week 10 Endocrine Flashcards

1
Q

metformin (Glucophage) class

A

biguanides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

metformin (Glucophage) therapeutic use

A

first line drug to treat type III diabetes because it does not cause weight gain, can be taken with other oral meds and insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

metformin (Glucophage) EPA

A

Reduces the production of glucose by the liver, decreases absorption of glucose from the intestines & increases sensitivity of insulin receptors in tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

metformin (Glucophage) ADRs

A

lactic acidosis
nausea, vomiting, diarrhea
metallic taste

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

metformin (Glucophage) black box warning

A

risk for potentially fatal lactic acidosis for people with a history because it increases production of lactate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

metformin (Glucophage) contraindications and interactions

A

not given during severe illness, surgery, hospitalization
pregnancy
renal or hepatic impairment
history of lactic acidosis
alcohol use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

metformin (Glucophage) interventions and education

A

take with meals
do not stop without consulting provider
avoid alcohol
cannot be taken within 48 hours of contrast imaging due to kidney injury risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

glipizide (Glucotrol) class

A

sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

glipizide (Glucotrol) therapeutic use

A

use in combination with diet to lower blood sugar levels in patients with type II diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

glipizide (Glucotrol) EPA

A

stimulates pancreatic beta cells to produce more insulin, increasing secretion of insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

glipizide (Glucotrol) ADRs

A

hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

glipizide (Glucotrol) contraindications and interactions

A

allergy to sulfa meds
pregnancy
renal or hepatic dysfuntions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

glipizide (Glucotrol) interventions and education

A

take 30 minutes before meals
do not give during severe illness, surgery, hospitalization, or pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

regular insulin class

A

short-acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

regular insulin therapeutic use

A

control blood sugar in pataients with type I diabetes or type II diabetes not controlled by diet, exercise, or oral agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

regular insulin EPA

A

onset in 30-60 minutes
replaces endogenous insulin and has same effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

regular insulin ADRs

A

hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

regular insulin contraindications and interactions

A

hypoglycemia
lower dose for renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

regular insulin interventions and education

A

how to store and administer insulin
what to do if hypoglycemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

lispro insulin (Humalog) class

A

rapid-acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

lispro insulin (Humalog) therapeutic use

A

given with meals to to correct high blood glucose level
can be used for type I or type II diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

lispro insulin (Humalog) EPA

A

quick onset, 15 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

lispro insulin (Humalog) ADRs

A

hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

lispro insulin (Humalog) contraindications and interactions

A

hypoglycemia
lower dose for renal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

lispro insulin (Humalog) interventions and education

A

how to store and administer insulin
what to do if hypoglycemic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

glargine insulin (Lantus) class

A

long-acting insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

glargine insulin (Lantus) therapeutic use

A

control blood sugar in type I diabetes or type II not controlled with diet, exercise, or oral medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

glargine insulin (Lantus) EPA

A

onset after 2 hours, no peak
acts like basal insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

glargine insulin (Lantus) ADRs

A

hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

glargine insulin (Lantus) contraindications and interactions

A

hypoglycemia
lower dose for renal disease

31
Q

glargine insulin (Lantus) interventions and education

A

how to store and administer insulin
what to do if hypoglycemic

32
Q

insulin injection sites

A

injected subQ: abdomen, posterior upper arm, anterior thigh, hips

33
Q

insulin administration

A

prime insulin pen with 2 units
dial up correct dose
locate injection site and clean with alcohol
hold and pinch area with non dominant hand, inject at 90 degrees
hold in place for 5 seconds after administration
do not inject into limb that will be exercised, will cause faster absorption

34
Q

glucagon (GlucaGen) class

A

hyperglycemics

35
Q

glucagon (GlucaGen) therapeutic use

A

treat hypoglycemia from insulin overdose

36
Q

glucagon (GlucaGen) EPA

A

raises blood levels of glucose through glycogenesis

37
Q

glucagon (GlucaGen) ADRs

A

nausea and vomiting

38
Q

glucagon (GlucaGen) contraindications and interactions

A

hypersensitivity

39
Q

glucagon (GlucaGen) interventions and educationn

A

turn patient on side if unconscious
provide food once patient regains consciousness and can swallow
educate on signs of hypoglycemia

40
Q

levothyroxine (Synthroid) class

A

thyroid replacement

41
Q

levothyroxine (Synthroid) therapeutic use

A

lifelong treatment for hypothyroidism

42
Q

levothyroxine (Synthroid) EPA

A

synthetic T4 to increase metabolic rate

43
Q

levothyroxine (Synthroid) ADRs

A
  • signs and symptoms of hyperthyroidism
  • thyrotoxicosis
44
Q

levothyroxine (Synthroid) interventions and education

A
  • monitor T3, T4, TSH levels.
  • measure baseline ad periodic VS and weight
45
Q

levothyroxine (Synthroid) contraindications and interactions

A

thyrotoxicosis
recent MI
food decreases absorption

46
Q

signs and symptoms of hyperthyroidism

A

rapid heart rate, palpitations, chest pain.
nervousness
tremors
decreased appetite
heat intolerance, fever, sweating
weight loss

47
Q

propylthiouracil (PTU) class

A

antithyroid: thioamides

48
Q

propylthiouracil (PTU) therapeutic use

A
  • grave’s disease
  • thyrotoxicosis
  • suppression of thyroid hormone prior to thyroidectomy
49
Q

propylthiouracil (PTU) EPA

A

blocks iodine from integrating into tyrosine, blocks T4 from converting into T3

50
Q

propylthiouracil (PTU) ADRs

A

signs and symptoms of hypothyroidism
agranulocytosis
anemia
hepatotoxicity
rash
nausea and vomiting
headache
dizziness

51
Q

propylthiouracil (PTU) interventions and education

A

monitor T4, T4, TSH
baseline and regular VS and weight
educate on signs of hypothyroidism - fatigue, weakness, weight gain, cold intolerance
monitor CBC, report fever and sore throat

52
Q

propylthiouracil (PTU) contraindications and interactions

A

teratogenic
caution with immunosuppression and infections
liver dysfunction

53
Q

desmopressin (DDAVP) class

A

posterior pituitary hormone drug

54
Q

desmopressin (DDAVP) therapeutic use

A

diabetes insipidus

55
Q

desmopressin (DDAVP) EPA

A

synthetic ADH

56
Q

desmopressin (DDAVP) ADRs

A

fluid retention: hyponatremia a nd edema
seizures

57
Q

desmopressin (DDAVP) interventions and education

A

H2O intoxication: headache, confusion
decrease water intake
strict I&O
monitor serum sodium

58
Q

desmopressin (DDAVP) contraindications and interactions

A

renal failure
nephrogenic diabetes insipidus
electrolyte imbalances

59
Q

hydrocortisone (Cortef) class

A

glucocorticoids

60
Q

hydrocortisone (Cortef) therapeutic use

A

addison’s disease/ adrenal insufficiency.
autoimmune inflammatory disorders.
asthma.

61
Q

hydrocortisone (Cortef) EPA

A

synthetic cortisol

62
Q

hydrocortisone (Cortef) ADRs

A

many at high levels

63
Q

hydrocortisone (Cortef) interventions and education

A

monitor CBC, electrolytes, glucose, glucocorticoid levels.
may need supplemental dose in time of stress.
medical alert bracelet.
call provider before getting vaccines.

64
Q

hydrocortisone (Cortef) contraindications and interactions

A

oral contraceptives
phenytoin and phenobarbital

65
Q

fludrocortisone class

A

mineralocorticoids

66
Q

fludrocortisone therapeutic use

A
  • addison’s disease
    adrenal insufficiency
  • primary hypoaldosteronism
  • congenital adrenal hyperplasia
67
Q

fludrocortisone EPA

A

synthetic aldosterone
sodium and water retention

68
Q

fludrocortisone ADRs

A

fluid and electrolyte imbalances
hypertension, heart failure, hypokalemia

69
Q

fludrocortisone interventions and education

A

monitor fluid retention, weight
monitor BP
monitor potassium levels
monitor inadequate dosage: weight loss, poor appetite, fatigue, muscle weakness, hypotension

70
Q

somatropin class

A

growth hormone

71
Q

somatropin therapeutic use

A

turner’s syndrome
GH deficiency
wasting syndrome - AIDs

72
Q

somatropin administration

A

rotate subQ sites

73
Q

somatropin interventions

A

monitor urinary calcium due to risk of hypercalciuria

74
Q

somatropin ADRs

A

hyperglycemia